Elixirr International (LON:ELIX) Stock Price Down 2.3% – Here’s What Happened

Elixirr International plc (LON:ELIX) was down 2.3% during mid-day trading on Wednesday. The company traded as low as GBX 506 and last traded at GBX 506. Approximately 198,139 shares traded hands during trading, an increase of 67% from the average session volume of 118,351 shares. The stock had previously closed at GBX 518.

Analyst Upgrades and Downgrades

ELIX has been the topic of a number of recent analyst reports. Berenberg Bank reissued a “buy” rating and set a GBX 1,060 price target on shares of Elixirr International in a research note on Monday, September 21st. Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 1,275 price target on shares of Elixirr International in a research report on Monday, September 21st. Two research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, Elixirr International currently has an average rating of “Buy” and an average target price of GBX 1,167.50.

Elixirr International Price Performance

The stock has a market capitalization of £254.20 million, a price-to-earnings ratio of 13.12 and a beta of 0.65. The company has a quick ratio of 1.29, a current ratio of 0.80 and a debt-to-equity ratio of 41.61. The firm has a 50-day moving average of GBX 579.28 and a two-hundred day moving average of GBX 651.66.

Elixirr International (LON:ELIX) last issued its earnings results on Monday, September 21st. The company reported GBX 37.50 earnings per share (EPS) for the quarter. Elixirr International had a net margin of 12.58% and a return on equity of 14.24%. As a group, sell-side analysts anticipate that Elixirr International plc will post 44.52 earnings per share for the current year.

Elixirr International Company Profile

Elixirr is a global consulting firm with a bold ambition: to become the best consulting firm in the world.

Founded in 2009 to challenge a declining industry standard, we’ve grown from a single vision into a powerhouse of entrepreneurial talent. We partner with businesses around the world to deliver transformational results, from boardroom strategy through to execution, powered by the technology of tomorrow. We do this in a way that’s anything but traditional – helping our clients change the game in their industries, just as we are changing the game in ours.